Indeed, to facilitate diagnosis of early-stage malignant tumors and novel effective immunotherapies, Nakanishi et al. have detected specific antibodies against PRDX6 in peripheral blood from patients with esophageal squamous carcinoma and lung adenocarcinoma [149,176]. The gene discussed is PRDX6; the disease is cancer.